Petriage awarded U.S. patent for telehealth technology
This is Petriage’s second U.S. patent that will expand its AI-driven symptom analysis tool to telemedicine beyond pets.
Petriage, a pet health technology company, announced in an organizational statement1 that the U.S. Patent and Trademark Office granted them a new patent that will be issued on June 7, 2022. This patent is the company’s second and includes teletraining for all animals, including humans. .
With this new patent, Petriage plans to further develop its unique artificial intelligence-driven symptom analysis and triage technology to offer similar telehealth solutions for human health care. These developments include a symptom analysis tool to identify human diseases with increasing levels of urgency, virtual consultations with physicians, and automated remote monitoring.1
Petriage was designed to offer telehealth services fully integrated with veterinary practices and their clients. The company’s platform provides a way for veterinarians to communicate with clients and care for pets remotely, including a patented teletreatment application in which pet parents receive a real-time recommendation on the need and the urgency of seeking medical attention for their pets.
When Petriage applied for a patent on its pet evaluation and triage system, which was granted by the U.S. Patent and Trademark Office in February 2021 for 20 years, the company also began a path to long-term to approve a patent that expands the scope and language to cover it. all animals.
Joe Coury, CEO of Petriage, spoke about this technological development and the extension to human health, stating that “We could imagine using these learnings to provide humans with the right telehealth information at the right time.”1
Co-founders Shlomo Freiman, DVM, Casey Olives, Ph.D. and Allon Freiman developed the company’s system algorithm and analysis tool.
“Our original impetus was to empower veterinarians like me and offer their clients peace of mind by taking advantage of AI to provide remote care to patients,” Freiman said. “But the 97% more accuracy of the AI-driven symptom analysis tool has surpassed what we initially imagined.”
Olives added: “What has been so exciting is that our unique machine learning model for health data is demonstrating how to marry the clinical side with the side of data science, first with pets and now potentially. for humans “.
Petriage granted a U.S. patent for AI-powered telehealth technology beyond pets. News release. Petriatge. May 20, 2022.